BioKnow
@bioknow.bsky.social
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: buff.ly/65vWn7D
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: buff.ly/65vWn7D
May 14, 2025 at 10:03 AM
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: buff.ly/65vWn7D
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: buff.ly/65vWn7D
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
London Biotechnology Show
The London Biotechnology Show aims to accentuate the progress of biotechnology in the United Kingdom and around the world by bringing together leading industry experts and key stakeholders from the en...
tinyurl.com
March 18, 2025 at 11:45 AM
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Top Pharma Companies by 2024 Pipeline Size 🧬
Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. 🏆
#biotech #biopharma #pharma
Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. 🏆
#biotech #biopharma #pharma
March 18, 2025 at 9:00 AM
Top Pharma Companies by 2024 Pipeline Size 🧬
Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. 🏆
#biotech #biopharma #pharma
Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. 🏆
#biotech #biopharma #pharma
New Biologics Companies Launched👇
2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more.
Credit/Source: biopharma
#celltherapy #biopharma
2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more.
Credit/Source: biopharma
#celltherapy #biopharma
March 17, 2025 at 1:01 PM
New Biologics Companies Launched👇
2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more.
Credit/Source: biopharma
#celltherapy #biopharma
2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more.
Credit/Source: biopharma
#celltherapy #biopharma
🚨 BREAKING: Scientists Achieve Removal of Extra Chromosome in Down Syndrome! 🧬
Major milestone as researchers have used CRISPR-Cas9 technology to remove the extra copy of chromosome 21 in human cells—marking a significant step forward in genetic research!
🔗 Read the full article: buff.ly/yC4CZji
Major milestone as researchers have used CRISPR-Cas9 technology to remove the extra copy of chromosome 21 in human cells—marking a significant step forward in genetic research!
🔗 Read the full article: buff.ly/yC4CZji
March 17, 2025 at 9:00 AM
🚨 BREAKING: Scientists Achieve Removal of Extra Chromosome in Down Syndrome! 🧬
Major milestone as researchers have used CRISPR-Cas9 technology to remove the extra copy of chromosome 21 in human cells—marking a significant step forward in genetic research!
🔗 Read the full article: buff.ly/yC4CZji
Major milestone as researchers have used CRISPR-Cas9 technology to remove the extra copy of chromosome 21 in human cells—marking a significant step forward in genetic research!
🔗 Read the full article: buff.ly/yC4CZji
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
March 13, 2025 at 4:27 PM
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
FREE Biotech Newsletter:
Your quick way to the latest breakthroughs...
90% of our subscribers report feeling more informed about biotech developments.
Join a community of 18,000+ biotech enthusiasts who share insights and updates weekly!
Join here: lnkd.in/decTJM6Q
#Biotech #Biopharma
Your quick way to the latest breakthroughs...
90% of our subscribers report feeling more informed about biotech developments.
Join a community of 18,000+ biotech enthusiasts who share insights and updates weekly!
Join here: lnkd.in/decTJM6Q
#Biotech #Biopharma
Newsletter Sign Up
dashboard.mailerlite.com
March 4, 2025 at 3:28 PM
FREE Biotech Newsletter:
Your quick way to the latest breakthroughs...
90% of our subscribers report feeling more informed about biotech developments.
Join a community of 18,000+ biotech enthusiasts who share insights and updates weekly!
Join here: lnkd.in/decTJM6Q
#Biotech #Biopharma
Your quick way to the latest breakthroughs...
90% of our subscribers report feeling more informed about biotech developments.
Join a community of 18,000+ biotech enthusiasts who share insights and updates weekly!
Join here: lnkd.in/decTJM6Q
#Biotech #Biopharma
𝐀𝐥𝐥 𝐜𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐦𝐦𝐮𝐧𝐞 𝐒𝐲𝐬𝐭𝐞𝐦:
The immune system is a complex network of cells, tissues, and organs that defends the body against pathogens like bacteria, viruses, fungi, and parasites.
Source: BioTecNika
#immunology #oncology #biotech #celltherapy
The immune system is a complex network of cells, tissues, and organs that defends the body against pathogens like bacteria, viruses, fungi, and parasites.
Source: BioTecNika
#immunology #oncology #biotech #celltherapy
March 4, 2025 at 3:27 PM
𝐀𝐥𝐥 𝐜𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐦𝐦𝐮𝐧𝐞 𝐒𝐲𝐬𝐭𝐞𝐦:
The immune system is a complex network of cells, tissues, and organs that defends the body against pathogens like bacteria, viruses, fungi, and parasites.
Source: BioTecNika
#immunology #oncology #biotech #celltherapy
The immune system is a complex network of cells, tissues, and organs that defends the body against pathogens like bacteria, viruses, fungi, and parasites.
Source: BioTecNika
#immunology #oncology #biotech #celltherapy
Companies Focused on Neuroinflammatory Targets 👇
72 biopharmaceutical companies below categorised by Preclinical to Phase III and based in therapeutic areas such as CNS, Gene Therapy and iPSCs.
- NLPR 3
- PGRN
- TREM2
- Other
#neurology #biotech #genetherapy #biopharma
72 biopharmaceutical companies below categorised by Preclinical to Phase III and based in therapeutic areas such as CNS, Gene Therapy and iPSCs.
- NLPR 3
- PGRN
- TREM2
- Other
#neurology #biotech #genetherapy #biopharma
March 4, 2025 at 3:25 PM
Companies Focused on Neuroinflammatory Targets 👇
72 biopharmaceutical companies below categorised by Preclinical to Phase III and based in therapeutic areas such as CNS, Gene Therapy and iPSCs.
- NLPR 3
- PGRN
- TREM2
- Other
#neurology #biotech #genetherapy #biopharma
72 biopharmaceutical companies below categorised by Preclinical to Phase III and based in therapeutic areas such as CNS, Gene Therapy and iPSCs.
- NLPR 3
- PGRN
- TREM2
- Other
#neurology #biotech #genetherapy #biopharma
Biopharma M&A Heats Up:
Top 20 Deals by Valuation (2023-2025 YTD) 💰💊
The biopharma industry continues its M&A momentum, with oncology, CNS, and I&I emerging as the most sought-after therapeutic areas.
Credit/Source: Bloomberg & Deutsche Bank
#biotech #biopharma #pharmaceuticals #neurology
Top 20 Deals by Valuation (2023-2025 YTD) 💰💊
The biopharma industry continues its M&A momentum, with oncology, CNS, and I&I emerging as the most sought-after therapeutic areas.
Credit/Source: Bloomberg & Deutsche Bank
#biotech #biopharma #pharmaceuticals #neurology
February 22, 2025 at 3:56 PM
Biopharma M&A Heats Up:
Top 20 Deals by Valuation (2023-2025 YTD) 💰💊
The biopharma industry continues its M&A momentum, with oncology, CNS, and I&I emerging as the most sought-after therapeutic areas.
Credit/Source: Bloomberg & Deutsche Bank
#biotech #biopharma #pharmaceuticals #neurology
Top 20 Deals by Valuation (2023-2025 YTD) 💰💊
The biopharma industry continues its M&A momentum, with oncology, CNS, and I&I emerging as the most sought-after therapeutic areas.
Credit/Source: Bloomberg & Deutsche Bank
#biotech #biopharma #pharmaceuticals #neurology
Visualizing smLiveFISH-labelled MAP1B RNAs in Live Cells using CRISPR-csm.
#genetherapy #biotech #biopharma #crispr
#genetherapy #biotech #biopharma #crispr
February 22, 2025 at 3:54 PM
Visualizing smLiveFISH-labelled MAP1B RNAs in Live Cells using CRISPR-csm.
#genetherapy #biotech #biopharma #crispr
#genetherapy #biotech #biopharma #crispr
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
February 18, 2025 at 7:16 PM
Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
Connect, innovate & shape the future of biotech!
Register now: tinyurl.com/sscbx4nn
𝗔𝘂𝘁𝗶𝘀𝗺 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 👇
There are no hashtag FDA approved medications that directly target autism’s primary symptoms.
Source: Maryam Daneshpour / clinicaltrials.gov
#autism #neurology #biotech #biopharma
There are no hashtag FDA approved medications that directly target autism’s primary symptoms.
Source: Maryam Daneshpour / clinicaltrials.gov
#autism #neurology #biotech #biopharma
ClinicalTrials.gov
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
clinicaltrials.gov
February 18, 2025 at 9:00 AM
𝗔𝘂𝘁𝗶𝘀𝗺 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 👇
There are no hashtag FDA approved medications that directly target autism’s primary symptoms.
Source: Maryam Daneshpour / clinicaltrials.gov
#autism #neurology #biotech #biopharma
There are no hashtag FDA approved medications that directly target autism’s primary symptoms.
Source: Maryam Daneshpour / clinicaltrials.gov
#autism #neurology #biotech #biopharma
🚨 Exciting News! 🚨
BioKnow is thrilled to announce our partnership with Scientex Conferences for the International Conference on Cardiology and Cardio Care, happening November 28-29, 2025, in Paris, France! 🇫🇷
🔗 Learn more: lnkd.in/gkWrZ5yN
#CardiologyConference #CardioCare2025 #CardiovascularCare
BioKnow is thrilled to announce our partnership with Scientex Conferences for the International Conference on Cardiology and Cardio Care, happening November 28-29, 2025, in Paris, France! 🇫🇷
🔗 Learn more: lnkd.in/gkWrZ5yN
#CardiologyConference #CardioCare2025 #CardiovascularCare
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
February 17, 2025 at 8:51 PM
🚨 Exciting News! 🚨
BioKnow is thrilled to announce our partnership with Scientex Conferences for the International Conference on Cardiology and Cardio Care, happening November 28-29, 2025, in Paris, France! 🇫🇷
🔗 Learn more: lnkd.in/gkWrZ5yN
#CardiologyConference #CardioCare2025 #CardiovascularCare
BioKnow is thrilled to announce our partnership with Scientex Conferences for the International Conference on Cardiology and Cardio Care, happening November 28-29, 2025, in Paris, France! 🇫🇷
🔗 Learn more: lnkd.in/gkWrZ5yN
#CardiologyConference #CardioCare2025 #CardiovascularCare
Algae Biotechnology Market 👇
Here’s a quick look at key algae biotechnology companies by region—spanning North America, Europe, and Asia—as highlighted in this visual by BioKnow. 🚀
#algae #biotech #biopharma
Here’s a quick look at key algae biotechnology companies by region—spanning North America, Europe, and Asia—as highlighted in this visual by BioKnow. 🚀
#algae #biotech #biopharma
February 17, 2025 at 3:00 PM
Algae Biotechnology Market 👇
Here’s a quick look at key algae biotechnology companies by region—spanning North America, Europe, and Asia—as highlighted in this visual by BioKnow. 🚀
#algae #biotech #biopharma
Here’s a quick look at key algae biotechnology companies by region—spanning North America, Europe, and Asia—as highlighted in this visual by BioKnow. 🚀
#algae #biotech #biopharma
Global Pharma Leaders of 2024:
A Billion-Dollar Industry on the Rise 👇
🔹 Johnson & Johnson leads the pack with an impressive $88.8 billion in revenue.
🔹 Pfizer, Merck, and AbbVie follow closely, with revenues exceeding $55 billion each.
#pharma #biopharma
A Billion-Dollar Industry on the Rise 👇
🔹 Johnson & Johnson leads the pack with an impressive $88.8 billion in revenue.
🔹 Pfizer, Merck, and AbbVie follow closely, with revenues exceeding $55 billion each.
#pharma #biopharma
February 16, 2025 at 4:00 PM
Global Pharma Leaders of 2024:
A Billion-Dollar Industry on the Rise 👇
🔹 Johnson & Johnson leads the pack with an impressive $88.8 billion in revenue.
🔹 Pfizer, Merck, and AbbVie follow closely, with revenues exceeding $55 billion each.
#pharma #biopharma
A Billion-Dollar Industry on the Rise 👇
🔹 Johnson & Johnson leads the pack with an impressive $88.8 billion in revenue.
🔹 Pfizer, Merck, and AbbVie follow closely, with revenues exceeding $55 billion each.
#pharma #biopharma
Global ADC Market 👇
The #ADC market is experiencing rapid growth, with forecasts indicating a global market size exceeding $18B by 2025, driven by the increasing adoption of targeted #cancer #therapies and the success of key ADCs.
Credits: PharmaSights, Alexander Bonebakker
The #ADC market is experiencing rapid growth, with forecasts indicating a global market size exceeding $18B by 2025, driven by the increasing adoption of targeted #cancer #therapies and the success of key ADCs.
Credits: PharmaSights, Alexander Bonebakker
February 13, 2025 at 11:45 AM
Global ADC Market 👇
The #ADC market is experiencing rapid growth, with forecasts indicating a global market size exceeding $18B by 2025, driven by the increasing adoption of targeted #cancer #therapies and the success of key ADCs.
Credits: PharmaSights, Alexander Bonebakker
The #ADC market is experiencing rapid growth, with forecasts indicating a global market size exceeding $18B by 2025, driven by the increasing adoption of targeted #cancer #therapies and the success of key ADCs.
Credits: PharmaSights, Alexander Bonebakker
2024 FDA Oncology Approvals ✅
The FDA approved 50 novel drugs last year, with oncology and hematology leading. A key approval was Datroway (datopotamab deruxtecan) for metastatic HR-positive, HER2-negative breast cancer.
Credit: Maryam Daneshpour
#oncology #immunotherapy
The FDA approved 50 novel drugs last year, with oncology and hematology leading. A key approval was Datroway (datopotamab deruxtecan) for metastatic HR-positive, HER2-negative breast cancer.
Credit: Maryam Daneshpour
#oncology #immunotherapy
February 12, 2025 at 9:02 AM
2024 FDA Oncology Approvals ✅
The FDA approved 50 novel drugs last year, with oncology and hematology leading. A key approval was Datroway (datopotamab deruxtecan) for metastatic HR-positive, HER2-negative breast cancer.
Credit: Maryam Daneshpour
#oncology #immunotherapy
The FDA approved 50 novel drugs last year, with oncology and hematology leading. A key approval was Datroway (datopotamab deruxtecan) for metastatic HR-positive, HER2-negative breast cancer.
Credit: Maryam Daneshpour
#oncology #immunotherapy
Radiopharma Market 👇
The graph shows a list of FDA-approved radiopharmaceuticals in compliance with USP <825> standards.
The #nuclear medicine market is experiencing rapid growth and projected to reach USD $13.10B by 2032, with a CAGR of 9.10%.
#oncology #radiopharma
The graph shows a list of FDA-approved radiopharmaceuticals in compliance with USP <825> standards.
The #nuclear medicine market is experiencing rapid growth and projected to reach USD $13.10B by 2032, with a CAGR of 9.10%.
#oncology #radiopharma
February 11, 2025 at 9:00 AM
Radiopharma Market 👇
The graph shows a list of FDA-approved radiopharmaceuticals in compliance with USP <825> standards.
The #nuclear medicine market is experiencing rapid growth and projected to reach USD $13.10B by 2032, with a CAGR of 9.10%.
#oncology #radiopharma
The graph shows a list of FDA-approved radiopharmaceuticals in compliance with USP <825> standards.
The #nuclear medicine market is experiencing rapid growth and projected to reach USD $13.10B by 2032, with a CAGR of 9.10%.
#oncology #radiopharma
🩸 The Evolution of Immune Cell Discoveries & Technologies! 🔬✨
From the first observation of blood cells in 1658 to the identification of steroid-producing Th2 cells in 2015, the study of immune cells has transformed dramatically! 🚀
CREDIT: Ayesha Tabassum
From the first observation of blood cells in 1658 to the identification of steroid-producing Th2 cells in 2015, the study of immune cells has transformed dramatically! 🚀
CREDIT: Ayesha Tabassum
February 10, 2025 at 7:30 AM
🩸 The Evolution of Immune Cell Discoveries & Technologies! 🔬✨
From the first observation of blood cells in 1658 to the identification of steroid-producing Th2 cells in 2015, the study of immune cells has transformed dramatically! 🚀
CREDIT: Ayesha Tabassum
From the first observation of blood cells in 1658 to the identification of steroid-producing Th2 cells in 2015, the study of immune cells has transformed dramatically! 🚀
CREDIT: Ayesha Tabassum
Reposted by BioKnow
Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic.
globalnews.ca/news/9793403...
globalnews.ca/news/9793403...
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
globalnews.ca
February 9, 2025 at 5:38 PM
Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic.
globalnews.ca/news/9793403...
globalnews.ca/news/9793403...
Reposted by BioKnow
Nature research paper: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
https://go.nature.com/4gtHiuX
https://go.nature.com/4gtHiuX
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma - Nature
A phase I trial of a neoantigen-targeting personalized cancer vaccine led to durable and polyfunctional T cell responses and antitumour recognition, and was associated with no recurrence in patients with high-risk clear cell renal cell carcinoma.
go.nature.com
February 6, 2025 at 6:55 PM
Nature research paper: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
https://go.nature.com/4gtHiuX
https://go.nature.com/4gtHiuX
Reposted by BioKnow
Nature research paper: Millihertz oscillations near the innermost orbit of a supermassive black hole
https://go.nature.com/3WNcI8w
https://go.nature.com/3WNcI8w
Millihertz oscillations near the innermost orbit of a supermassive black hole - Nature
A millihertz frequency X-ray quasi-periodic oscillation has been observed near the innermost orbit of an actively accreting supermassive black hole and its frequency has evolved significantly over 2 years, a phenomenon that is difficult to explain with existing models.
go.nature.com
February 7, 2025 at 4:07 PM
Nature research paper: Millihertz oscillations near the innermost orbit of a supermassive black hole
https://go.nature.com/3WNcI8w
https://go.nature.com/3WNcI8w
FREE #Biotech Newsletter: dashboard.mailerlite.com/forms/996595...
Your gateway to the latest breakthroughs, so you're never left behind.
🔔 Be at the Forefront with critical #updates and #insights.
🔥 Don’t Miss a Beat in the evolving world of biotech!
Your gateway to the latest breakthroughs, so you're never left behind.
🔔 Be at the Forefront with critical #updates and #insights.
🔥 Don’t Miss a Beat in the evolving world of biotech!
Newsletter Sign Up
dashboard.mailerlite.com
February 9, 2025 at 2:07 PM
FREE #Biotech Newsletter: dashboard.mailerlite.com/forms/996595...
Your gateway to the latest breakthroughs, so you're never left behind.
🔔 Be at the Forefront with critical #updates and #insights.
🔥 Don’t Miss a Beat in the evolving world of biotech!
Your gateway to the latest breakthroughs, so you're never left behind.
🔔 Be at the Forefront with critical #updates and #insights.
🔥 Don’t Miss a Beat in the evolving world of biotech!